BMY
Price
$48.50
Change
+$0.84 (+1.76%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
109.66B
21 days until earnings call
JNJ
Price
$157.64
Change
+$1.36 (+0.87%)
Updated
Jul 10, 04:59 PM (EDT)
Capitalization
380.22B
6 days until earnings call
Interact to see
Advertisement

BMY vs JNJ

Header iconBMY vs JNJ Comparison
Open Charts BMY vs JNJBanner chart's image
Bristol-Myers Squibb
Price$48.50
Change+$0.84 (+1.76%)
Volume$87.97K
Capitalization109.66B
Johnson & Johnson
Price$157.64
Change+$1.36 (+0.87%)
Volume$30.76K
Capitalization380.22B
BMY vs JNJ Comparison Chart in %
Loading...
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMY vs. JNJ commentary
Jul 10, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMY is a StrongBuy and JNJ is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 10, 2025
Stock price -- (BMY: $47.66 vs. JNJ: $156.28)
Brand notoriety: BMY and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: BMY: 89% vs. JNJ: 80%
Market capitalization -- BMY: $109.66B vs. JNJ: $380.22B
BMY [@Pharmaceuticals: Major] is valued at $109.66B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMY’s FA Score shows that 2 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s).

  • BMY’s FA Score: 2 green, 3 red.
  • JNJ’s FA Score: 2 green, 3 red.
According to our system of comparison, JNJ is a better buy in the long-term than BMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMY’s TA Score shows that 6 TA indicator(s) are bullish while JNJ’s TA Score has 8 bullish TA indicator(s).

  • BMY’s TA Score: 6 bullish, 4 bearish.
  • JNJ’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than BMY.

Price Growth

BMY (@Pharmaceuticals: Major) experienced а +1.38% price change this week, while JNJ (@Pharmaceuticals: Major) price change was +0.46% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was +0.89%. For the same industry, the average monthly price growth was +0.62%, and the average quarterly price growth was +10.51%.

Reported Earning Dates

BMY is expected to report earnings on Oct 30, 2025.

JNJ is expected to report earnings on Oct 21, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (+0.89% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than BMY($110B). JNJ has higher P/E ratio than BMY: JNJ (30.34) vs BMY (13.73). JNJ YTD gains are higher at: 9.861 vs. BMY (-12.746). JNJ has higher annual earnings (EBITDA): 23.3B vs. BMY (19.4B). JNJ has more cash in the bank: 22.9B vs. BMY (12.3B). JNJ has less debt than BMY: JNJ (29.3B) vs BMY (41.5B). JNJ has higher revenues than BMY: JNJ (85.2B) vs BMY (45B).
BMYJNJBMY / JNJ
Capitalization110B380B29%
EBITDA19.4B23.3B83%
Gain YTD-12.7469.861-129%
P/E Ratio13.7330.3445%
Revenue45B85.2B53%
Total Cash12.3B22.9B54%
Total Debt41.5B29.3B142%
FUNDAMENTALS RATINGS
BMY vs JNJ: Fundamental Ratings
BMY
JNJ
OUTLOOK RATING
1..100
6116
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
9539
SMR RATING
1..100
3033
PRICE GROWTH RATING
1..100
6137
P/E GROWTH RATING
1..100
6080
SEASONALITY SCORE
1..100
6550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMY's Valuation (5) in the Pharmaceuticals Major industry is in the same range as JNJ (18). This means that BMY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Profit vs Risk Rating (39) in the Pharmaceuticals Major industry is somewhat better than the same rating for BMY (95). This means that JNJ’s stock grew somewhat faster than BMY’s over the last 12 months.

BMY's SMR Rating (30) in the Pharmaceuticals Major industry is in the same range as JNJ (33). This means that BMY’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's Price Growth Rating (37) in the Pharmaceuticals Major industry is in the same range as BMY (61). This means that JNJ’s stock grew similarly to BMY’s over the last 12 months.

BMY's P/E Growth Rating (60) in the Pharmaceuticals Major industry is in the same range as JNJ (80). This means that BMY’s stock grew similarly to JNJ’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMYJNJ
RSI
ODDS (%)
Bearish Trend 2 days ago
43%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 2 days ago
44%
Momentum
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
36%
MACD
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
33%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
52%
Bullish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
50%
Bullish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 2 days ago
55%
Bullish Trend 2 days ago
39%
Declines
ODDS (%)
Bearish Trend 4 days ago
54%
Bearish Trend 21 days ago
43%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
64%
Bullish Trend 2 days ago
42%
Aroon
ODDS (%)
Bullish Trend 2 days ago
47%
Bullish Trend 2 days ago
32%
View a ticker or compare two or three
Interact to see
Advertisement
BMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DUSL71.191.42
+2.04%
Direxion Dly Industrials Bull 3X ShsETF
LLYX16.020.28
+1.78%
Defiance Daily Target 2X Long LLY ETF
VIGI89.680.33
+0.37%
Vanguard Intl Div Apprec ETF
APMU24.800.03
+0.12%
ActivePassive Intermediate Mcpl Bd ETF
MUJ10.97N/A
N/A
Blackrock Muniholdings NEW Jersey Quality Fund

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
+0.31%
PFE - JNJ
59%
Loosely correlated
-0.23%
NVS - JNJ
55%
Loosely correlated
+1.04%
GSK - JNJ
52%
Loosely correlated
+1.46%
ABBV - JNJ
44%
Loosely correlated
+0.45%
AMGN - JNJ
44%
Loosely correlated
-0.16%
More